Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by biofoolon Jun 23, 2021 4:28am
253 Views
Post# 33432787

RE:RE:RE:Thoughts & Musings

RE:RE:RE:Thoughts & Musings
i join putin. let's keep it civil and fair.

two years ago would have been an honest update:

hey, our 0.2 concentration doesn't really interest anyone. we have to bring it to market ourselves somehow. with rodan & fields, we have an application for this that won't bring in significant sales. besides, we have to ensure production at two independent sites. all this will take at least two more years. then we'll see if we're more successful with a 0.4 concentration.
Wanbang will also take at least two more years.

what does sbm:

- Sensational launch with cosmetics giant number 1 imminent in north america and somehow also in japan.
- significant transaction and participation by new partners in china is imminent.
- sglt2 inhibitor phase II is imminent.
- in addition, a contract with two world market leaders for an sglt2 inhibitor for cats is imminent.

@sbm:
your milestone list is very welcome. your communication has improved compared to a few years ago. to achieve credibility you will have to travel a few more light years. or simply tell the truth.

if only half of what we are currently being led to believe is true, we would be standing somewhere else right now with some credibility.


<< Previous
Bullboard Posts
Next >>